Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says
Share this
Recent posts
-
Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar
-
Understanding real-world patterns of increasing oral semaglutide dose for obesity
-
Shingrix at 50: A good-news story for adult vaccination, healthy aging, and real-world study design
-
Shingrix vaccination is rising among newly eligible adults, but access gaps remain
-
Progesterone-containing hormone replacement therapy use is rising
Follow Truveta
Stay up-to-date